|
Aydemir G （2002）. Research on Nutrition and Cancer: The Importance of the Standardized Dietary Assessments. Asian Pacific Journal of Cancer Prevention 3: 177-180.
Baker AH, Edwards DR, Murphy G （2002）. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Science 115: 3719-3727.
Baluk P, Hashizume H, McDonald DM （2005）. Cellular abnormalities of blood vessels as targets in cancer. Current Opinion in Genetics &; Development 15: 102-111.
Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ （2004）. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clinical Chemistry and Laboratory Medicine 42: 121-131.
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D （2000）. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology 2: 737-744.
Bergers G, Benjamin LE （2003）. Tumorigenesis and the angiogenic switch. Nature Reviews Cancer 3: 401-410.
Bernhard EJ, Gruber SB, Muschel RJ （1994 ）. Direct evidence linking expression of matrix metalloproteinase-9 （92-kDa gelatinase/collagenase） to the metastatic phenotype in transformed rat embryo cells. Proceedings of the National Academy of Sciences of the United States of America 91: 4293-4297.
Bjorklund M, Koivunen E （2005）. Gelatinase-mediated migration and invasion of cancer cells. Biochimica et Biophysica Acta 1755: 37-69.
Bodenstine TM, Welch DR （2008）. Metastasis suppressors and the tumor microenvironment. Cancer Microenvironment 1: 1-11.
Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C, Schmidt-Ullrich RK（2001）. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene 20: 1388-1397.
Brew K, Dinakarpandian D, Nagase H （2000）. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 1477: 267-283.
Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O''Reilly MS （2001）. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Research 61: 2207-2211.
Chang CY, Lue MY, Pan TM （2005）. Determination of adenosine, cordycepin and ergosterol contents in cultivated Antrodia camphorata by HPLC method. Journal of Food and Drug Analysis 13: 338-342.
Chang TT, Chou WN （1995）. Antrodia cinnamomea Sp-Nov on Cinnamomum-Kanehirai in Taiwan. Mycological Research 99: 756-758.
Chang TT, Chou WN （2004 ）. Antrodia cinnamomea reconsidered and A-salmonea sp nov on Cunninghamia konishii in Taiwan. Botanical Studies 45: 347-352.
Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussen LM, DeClerck YA（2004）. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Research 64: 1675-1686.
Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E（2006）. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. European Journal of Cancer 42: 310-318.
Chen CH, Yang SW, Shen YC （1995）. New steroid acids from Antrodia cinnamomea, a fungal parasite of Cinnamomum micranthum. Journal of Natural Products 58: 1655-1661.
Chen YY, Chou PY, Chien YC, Wu CH, Wu TS, Sheu MJ （2012a）. Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways. Phytomedicine 19: 768-778.
Chen YY, Liu FC, Chou PY, Chien YC, Chang WS, Huang GJ, Wu CH, Sheu MJ（2012b）. Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways. Evidence-based Complementary and Alternative Medicine 2012: 378415.
Cheng JC, Chou CH, Kuo ML, Hsieh CY （2006）. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25: 7009-7018.
Cheng JJ, Huang NK, Chang TT, Wang DL, Lu MK （2005）. Study for anti-angiogenic activities of polysaccharides isolated from Antrodia cinnamomea in endothelial cells. Life Sciences 76: 3029-3042.
Cherng IH, Wu DP, Chiang HC （1996）. Triterpenoids from Antrodia cinnamomea. Phytochemistry 41: 263-267.
Chiang HC, Wu DP, Cherng IW, Ueng CH （1995）. A Sesquiterpene Lactone, Phenyl and Biphenyl Compounds from Antrodia cinnamomea. Phytochemistry 39: 613-616.
Chou CH, Teng CM, Tzen KY, Chang YC, Chen JH, Cheng JC （2012）. MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis. Oncogene 31: 458-468.
Coussens LM, Fingleton B, Matrisian LM （2002）. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
Crocker SJ, Pagenstecher A, Campbell IL （2004）. The TIMPs tango with MMPs and more in the central nervous system. Journal of Neuroscience Research 75: 1-11.
Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM （1993）. Tissue inhibitor of metalloproteinases （TIMP, aka EPA）: structure, control of expression and biological functions. Pharmacology &; Therapeutics 59: 329-341.
Du YC, Chang FR, Wu TY, Hsu YM, El-Shazly M, Chen CF, Sung PJ, Lin YY, Lin YH, Wu YC, Lu MC（2012）. Antileukemia component, dehydroeburicoic acid from Antrodia camphorata induces DNA damage and apoptosis in vitro and in vivo models. Phytomedicine 19: 788-796.
Egeblad M, Werb Z （2002）. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2: 161-174.
Ellis LM, Staley CA, Liu W, Fleming RY, Parikh NU, Bucana CD, Gallick GE （1998）. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. The Journal of Biological Chemistry 273: 1052-1057.
Esparza J, Vilardell C, Calvo J, Juan M, Vives J, Urbano-Marquez A, Yague J, Cid MC（1999）. Fibronectin upregulates gelatinase B （MMP-9） and induces coordinated expression of gelatinase A （MMP-2） and its activator MT1-MMP （MMP-14） by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94: 2754-2766.
Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA, Khokha R（2001）. Accelerated apoptosis in the Timp-3-deficient mammary gland. The Journal of Clinical Investigation 108: 831-841.
Ferrara N （2001）. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. American Journal of Physiology 280: 1358-1366.
Fidler IJ, Ellis LM （1994）. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188.
Fingleton B （2006）. Matrix metalloproteinases: roles in cancer and metastasis. Frontiers in Bioscience 11: 479-491.
Fink K, Boratynski J （2012）. The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis. Post&;#281;py Higieny i Medycyny Do&;#347;wiadczalnej 66: 609-628.
Folkman J （1971）. Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine 285: 1182-1186.
Folkman J （1986）. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Research 46: 467-473.
Folkman J, Shing Y （1992）. Angiogenesis. The Journal of Biological Chemistry 267: 10931-10934.
Geethangili M, Tzeng YM （2011）. Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds. Evidence-based Complementary and Alternative Medicine 2011: 212641.
Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE（2001）. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Research 61: 2413-2419.
Gill SE, Pape MC, Khokha R, Watson AJ, Leco KJ （2003）. A null mutation for tissue inhibitor of metalloproteinases-3 （Timp-3） impairs murine bronchiole branching morphogenesis. Developmental Biology 261: 313-323.
Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Postlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rucklinger E, Greil R, Marth C（2009）. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. The New England Journal of Medicine 360: 679-691.
Godenschwege TA, Pohar N, Buchner S, Buchner E （2000）. Inflated wings, tissue autolysis and early death in tissue inhibitor of metalloproteinases mutants of Drosophila. European Journal of Cell Biology 79: 495-501.
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP （1997）. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European journal of cell biology 74: 111-122.
Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme, VP, Soff GA, Kufe DW, Weichselbaum RR（1998）. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Research 58: 5686-5689.
Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR（1999）. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Research 59: 3374-3378.
Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW （2002）. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Research 62: 1702-1706.
Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, Pontes JE, Crissman JC, Fridman R（1996）. High levels of tissue inhibitor of metalloproteinase-2 （TIMP-2） expression are associated with poor outcome in invasive bladder cancer. Cancer Research 56: 1654-1659.
Griscelli F, Li H, Cheong C, Opolon P, Bennaceur-Griscelli A, Vassal G, Soria J Soria C, Lu H, Perricaudet M, Yeh P（2000）. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proceedings of the National Academy of Sciences of the United States of America 97: 6698-6703.
Handsley MM, Edwards DR （2005）. Metalloproteinases and their inhibitors in tumor angiogenesis. International Journal of Cancer 115: 849-860.
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K （1992）. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 （TIMP-1） for a wide range of cells. A possible new growth factor in serum. Federation of European Biochemical Societise 298: 29-32.
Hess C, Vuong V, Hegyi I, Riesterer O, Wood J, Fabbro D, Glanzmann C, Bodis S, Pruschy M（2001）. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. British Journal of Cancer 85: 2010-2016.
Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M（2002）. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer cell 2: 289-300.
Hou L, Li Y, Jia YH, Wang B, Xin Y, Ling MY, Lu S（2001）. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. World Journal of Gastroenterology 7: 532-536.
Hseu YC, Chen SC, Chen HC, Liao JW, Yang HL （2008）. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo. Food and chemical toxicology 46: 2680-2688.
Hsieh YC, Rao YK, Whang-Peng J, Huang CY, Shyue SK, Hsu SL, Tzeng YM （2011）. Antcin B and its ester derivative from Antrodia camphorata induce apoptosis in hepatocellular carcinoma cells involves enhancing oxidative stress coincident with activation of intrinsic and extrinsic apoptotic pathway. Journal of Agricultural and Food Chemistry 59: 10943-10954.
Hsu YL, Kuo PL, Cho CY, Ni WC, Tzeng TF, Ng LT, Kuo YH, Lin CC（2007）. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappa B pathway. Food and Chemical Toxicology 45: 1249-1257.
Iniesta P, Moran A, De Juan C, Gomez A, Hernando F, Garcia-Aranda C, Frias C, Diaz-Lopez A, Rodriguez-Jimenez FJ, Balibrea JL, Benito M（2007）. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncology Reports 17: 217-223.
Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S （1998）. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Research 58: 1048-1051.
Jumper C, Cobos E, Lox C （2004）. Determination of the serum matrix metalloproteinase-9 （MMP-9）and tissue inhibitor of matrix metalloproteinase-1 （TIMP-1） in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respiratory Medicine 98: 173-177.
Kalluri R （2003）. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Reviews Cancer 3: 422-433.
Kawamata H, Kameyama S, Kawai K, Tanaka Y, Nan L, Barch DH, Stetler-Stevenson WG, Oyasu R（1995）. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. International Journal of Cancer 63: 568-575.
Kong Y, Poon R, Nadesan P, Di Muccio T, Fodde R, Khokha, Alman BA（2004）. Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis. Cancer Research 64: 5795-5803.
Lambert E, Dasse E, Haye B, Petitfrere E （2004）. TIMPs as multifacial proteins. Critical Reviews in Oncology/Hematology 49: 187-198.
Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y（2000）. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Research 60: 5565-5570.
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S （1980）. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68.
Liu J （1995）. Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology 49: 57-68.
Liu JJ, Huang TS, Hsu ML, Chen CC, Lin WS, Lu FJ, Chang WH （2004）. Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicology and Applied Pharmacology 201: 186-193.
Lu MK, Cheng JJ, Lai WL, Lin YR, Huang NK （2006）. Adenosine as an active component of Antrodia cinnamomea that prevents rat PC12 cells from serum deprivation-induced apoptosis through the activation of adenosine A（2A） receptors. Life Sciences 79: 252-258.
Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR （1996）. Tumor necrosis factor alpha （TNF-alpha） gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Research 56: 4311-4314.
McCarthy K, Maguire T, McGreal G, McDermott E, O''Higgins N, Duffy MJ （1999）. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. International Journal of Cancer 84: 44-48.
McCawley LJ, Matrisian LM （2000）. Matrix metalloproteinases: multifunctional contributors to tumor progression. Molecular Medicine Today 6: 149-156.
Mendes O, Kim HT, Stoica G （2005）. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clinical &; Experimental Metastasis 22: 237-246.
Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA （2007）. Immunomodulating and anticancer agents in the realm of macromycetes fungi （macrofungi）. International Immunopharmacology 7: 701-724.
Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP （1995）. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581.
Nabeshima K, Inoue T, Shimao Y, Sameshima T （2002）. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathology International 52: 255-264.
Nagase H, Woessner JF, Jr. （1999）. Matrix metalloproteinases. The Journal of Biological Chemistry 274: 21491-21494.
Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S （2005）. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clinical Cancer Research 11: 5158-5166.
Overall CM, King AE, Sam DK, Ong AD, Lau TT, Wallon UM, DeClerck YA, Atherstone J（1999）. Identification of the tissue inhibitor of metalloproteinases-2 （TIMP-2） binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. The Journal of biological chemistry 274: 4421-4429.
Park W, Oh YT, Han JH, Pyo H （2008）. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2. Journal of Experimental &; Clinical Cancer Research 27: 66.
Peng CC, Chen KC, Peng RY, Chyau CC, Su CH, Hsieh-Li HM （2007）. Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. Journal of Ethnopharmacology 109: 93-103.
Rundhaug JE （2005）. Matrix metalloproteinases and angiogenesis. Journal of cellular and Molecular Medicine 9: 267-285.
Shen YC, Yang SW, Lin CS, Chen CH, Kuo YH, Chen CF （1997）. Zhankuic acid F: A new metabolite from a formosan fungus Antrodia cinnamomea. Planta Medica 63: 86-88.
Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K, Seifert, M, Kubista E（2002）. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Research and Treatment 72: 69-77.
Sporn MB （1996）. The war on cancer. The Lancet 347: 1377-1381.
Stanley G, Harvey K, Slivova V, Jiang J, Sliva D （2005）. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochemical and Biophysical Research Communications 330: 46-52.
Stetler-Stevenson WG, Aznavoorian S, Liotta LA （1993a）. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annual Review of Cell Biology 9: 541-573.
Stetler-Stevenson WG, Liotta LA, Kleiner DE, Jr. （1993b）. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. The Federation of American Societies for Experimental Biology 7: 1434-1441.
Susskind H, Hymowitz MH, Lau YH, Atkins HL, Hurewitz AN, Valentine ES, Meek, AG, Zucker, S（2003）. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. International journal of radiation oncology biology physics 56: 1161-1169.
Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD Fridman R（1994）. Enhanced expression of tissue inhibitor of metalloproteinase-2 （TIMP-2） in the stroma of breast carcinomas correlates with tumor recurrence. International Journal of Cancer 59: 339-344.
Wasser SP, Weis AL （1999）. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Critical Reviews in Immunology 19: 65-96.
Wasser SP （2002）. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 60: 258-274.
Weng CJ, Chau CF, Yen GC, Liao JW, Chen DH, Chen KD （2009）. Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. Journal of Agricultural and Food Chemistry 57: 5049-5057.
Westermarck J, Kahari VM （1999）. Regulation of matrix metalloproteinase expression in turner invasion. The Journal of the Fedration of American Societies for Experimental Biology 13: 781-792.
Wu DP, Chiang HC （1995）. Constituents of Antrodia cinnamomea. Journal of The Chinese Chemical Society Taipei 42: 797-800.
Wu MT, Tzang BS, Chang YY, Chiu CH, Kang WY, Huang CH, Chen, YC.（2011）. Effects of Antrodia camphorata on alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. Journal of Agricultural and Food Chemistry 59: 4248-4254.
Wu SH, Ryvarden L, Chang TT （1997）. Antrodia camphorata （''niu-chang-chih''）, new combination of a medicinal fungus in Taiwan. Botanical Buletin-Academic Sinica 38: 273-275.
Yang HL, Kuo YH, Tsai CT, Huang YT, Chen SC, Chang H, Hseu YC（2011）. Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food and Chemical Toxicology 49: 290-298.
Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JHT, Lai GM, Tzeng YM （2009）. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Letters 285: 73-79.
Zhang J, Bai S, Tanase C, Nagase H, Sarras MP （2003）. The expression of tissue inhibitor of metalloproteinase 2 （TIMP-2） is required for normal development of zebrafish embryos. Development Genes and Evolution 213: 382-389.
Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto AJ （1992）. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. International Journal of Cancer 52: 366-371.
行政院衛生福利部統計處. （2013） 中華民國101年國人主要死因統計結果
&;#8195;
|